
|
|||||

Clinical BackgroundMinimally invasive spine surgery has been shown to be more successful than conventional surgery when applied to appropriately selected patients. Success rates for the Nucleotome procedure have consistently produced results greater than 75% and many over 80%. Complication rates for percutaneous spine procedures have consistently been reported at less than 1%, a considerable reduction from the normal 3% to 4% reported for open spine surgery. Minimally invasive spine surgery shares the advantages of low morbidity, reduces postoperative pain and short recovery time common to all successful minimally invasive surgical techniques. The design of the Nucleotome's tip adds to its safety because it will not cut annulus and the blunt end minimizes risk of penetrating opposite annulus. Well over 125,000 cases have been performed worldwide without a reported mortality associated with the procedure. |
Nucleotome® Benefits
Nucleotome Probes:
|
Clinical References
|
Ordering Information
|
|||||||||||||||||||||||